PAQR3
Progestin and adipoQ receptor family member 3
Also known as: PAQR3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6TCH7
- Gene
- PAQR3
- Ensembl
- ENSG00000163291
- Chromosome
- 4
- Canonical length
- 311 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a seven-transmembrane protein localized in the Golgi apparatus in mammalian cells. The encoded protein belongs to the progestin and adipoQ receptor (PAQR) family. This protein functions as a tumor suppressor by inhibiting the Raf/MEK/ERK signaling cascade. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>Q6TCH7|PAQR3
1 MHQKLLKSAH YIELGSYQYW PVLVPRGIRL YTYEQIPGSL KDNPYITDGY RAYLPSRLCI
61 KSLFILSNET VNIWSHLLGF FLFFTLGIYD MTSVLPSASA SREDFVICSI CLFCFQVCML
121 CSVGYHLFSC HRSEKTCRRW MALDYAGISI GILGCYVSGV FYAFYCNNYW RQVYLITVLA
181 MILAVFFAQI HPNYLTQQWQ RLRSIIFCSV SGYGVIPTLH WVWLNGGIGA PIVQDFAPRV
241 IVMYMIALLA FLFYISKVPE RYFPGQLNYL GSSHQIWHIL AVVMLYWWHQ STVYVMQYRH
301 SKPCPDYVSH LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAQR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 2.9 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 2.9 nTPM
- midbrain: 2.9 nTPM
- amygdala: 2.8 nTPM
- spleen: 2.3 nTPM
- spinal cord: 2.2 nTPM
- cerebral cortex: 2.1 nTPM
Single-cell type
- late spermatids: 231 nCPM
- cardiomyocytes: 172 nCPM
- mast cells: 139 nCPM
- early spermatids: 131 nCPM
- epicardial cells: 82 nCPM
- hofbauer cells: 65 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 2 nTPM
- white matter: 1.8 nTPM
- spinal cord: 1.7 nTPM
- cerebral cortex: 1.4 nTPM
- medulla oblongata: 1.2 nTPM
- pons: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of MAP kinase activity
- negative regulation of neuron projection development
- negative regulation of peptidyl-serine phosphorylation
- negative regulation of peroxisome proliferator activated receptor signaling pathway
- negative regulation of protein phosphorylation
- positive regulation of cholesterol biosynthetic process
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of SREBP signaling pathway
- protein localization to Golgi apparatus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PAQR3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAQR3 as an antibody target. Whether an autoantibody or antibody against PAQR3 could matter depends on whether native PAQR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAQR3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PAQR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...